+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Neonatal autoimmune thrombocytopenia: role of high-dose intravenous immunoglobulin G therapy



Neonatal autoimmune thrombocytopenia: role of high-dose intravenous immunoglobulin G therapy



Blut 59(1): 139-144



High-dose intravenous immunoglobulin G (IVIgG) therapy results in a rapid reversal of thrombocytopenia in over 80% of children with acute immune thrombocytopenic purpura (ITP). Comparable results were observed in eleven infants with an analogous condition, neonatal autoimmune thrombocytopenia (NATP), who received IVIgG (2 g/kg body weight) administered alone (n = 6) or in combination with steroids (n = 5). The median platelet count pre-IVIgG therapy was 25 X 10(9)/l (range 5 to 74 X 10(9)/l). The overall response rate to IVIgG therapy, administered alone or in combination with steroids was 75% (12 of 16 treatment episodes). A good response to therapy was defined as an increase in the platelet count to greater than or equal to 50 X 10(9)/l and at least twice the pre-treatment value at 48 h after completion of the IVIgG infusion. The rapid and generally excellent response to IVIgG therapy in infants with NATP suggests that this treatment approach should be considered as first-line therapy for severely thrombocytopenic infants with this self-limiting but potentially serious disorder.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 040780473

Download citation: RISBibTeXText

PMID: 2752172

DOI: 10.1007/bf00320267


Related references

High-dose intravenous gammaglobulin therapy for neonatal autoimmune thrombocytopenia. Journal of Pediatrics 112(5): 789-792, 1988

The early high-dose immunoglobulin treatment of neonatal autoimmune thrombocytopenia. Minerva Pediatrica 44(12): 593-594, 1992

A case of autoimmune neutropenia and thrombocytopenia effect of high dose intravenous immunoglobulin. Keio Journal of Medicine 34(4): 227-232, 1985

Treatment of autoimmune neonatal thrombocytopenia with high-dose intravenous immunoglobulins. Annales de Medecine Interne 141(2): 111-114, 1990

High-dose intravenous immunoglobulin in the prenatal management of neonatal alloimmune thrombocytopenia. Clinical and Laboratory Haematology 13(1): 75-79, 1991

Successful treatment of neonatal "autoimmune" thrombocytopenia with high-dose intravenous immunoglobulins. Haematologica 70(3): 276-277, 1985

Treatment of neonatal autoimmune thrombocytopenia with high dose intravenous gamma globulin. Pediatric Research 25(4 Part 2): 271A, 1989

Repeated single-dose intravenous immunoglobulin therapy for neonatal passive immune thrombocytopenia. Israel Journal of Medical Sciences 23(7): 844-845, 1987

High dose intravenous immunoglobulin ivig in the prenatal management of neonatal alloimmune thrombocytopenia nait. British Journal of Haematology 74(Suppl. 1): 38, 1990

High dose intravenous immunoglobulin in adults with idiopathic thrombocytopenia and autoimmune neutropenia and allosensitized patients with aplastic anemia and hemophilia a. Blut 49(3): 278, 1984

Antenatal fetal therapy for neonatal allo-immune thrombocytopenia with high dose immunoglobulin. British Journal of Obstetrics and Gynaecology 101(11): 1011-1013, 1994

High-dose intravenous immunoglobulin as single therapy in a child with autoimmune hemolytic anemia. Pediatric Hematology and Oncology 14(5): 487-490, 1997

High-dose intravenous immunoglobulin (IVIG) therapy in autoimmune skin blistering diseases. Clinical Reviews in Allergy and Immunology 38(2-3): 186-195, 2010

High-dose intravenous immunoglobulin therapy in neonatal immune haemolytic jaundice. Acta Paediatrica 88(2): 216-219, 1999

High-dose intravenous immunoglobulin therapy in neonatal immune haemolytic jaundice. Acta Paediatrica 89(3): 371-372, 2000